what about a second hand market ?
I couldn't fiind any ''for sale'' threads, especialy for older models , older but still useful
I couldn't fiind any ''for sale'' threads, especialy for older models , older but still useful
-
-
We really should start a for-sale forum. I haven't only because I and several users of the forum have been threatened (literally) by vendors for trying to sell equipment on here...as resale is "not allowed" by their terms of service. -
Allow Used Equipment Sales Postings
If you can legally resell your car, then you can legally resell your lab equipment. The vendors lawyers are blowing smoke.
Legal minds will ,of course, have various opinions ( at $300/hr., of course).
That said, the vendor might have some grounds to deny support and needed supplemental products. What good is a Gillette Mach 3 razor without a Gillette blade?
The vendors might think it's hurting sales but might want to rethink the issue. Hondas can usually command a premium precisely because there is less depreciation than with other brands ... so owners can resell their Accords and Civics more easily.
I recommend you go ahead and allow used equipment postings by assuming it's legal. If a vendor complains, go ahead and remove the post ... but do replace it with the vendors complaint. Then we'll know what's what and can "re-brand" that vendor in our own minds. Perhaps a little market pressure will keep any bullies in line.Comment
-
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...10-14-2026, 09:55 AM -
Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.
We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing...
Comment